drug
rivastigmine ER
Marketedupdated 3mo agoby Mylan Technologies Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2indications
investigational
Alzheimer's DiseaseParkinson's Disease
all catalysts(1)
Trials studying rivastigmine ER
- phase1Rivastigmine Transdermal Patches Bioequivalence and Adhesion Assessment
- phase2Safety and Efficacy of AR1005 in Patients with Lewy Body Disease
- phase4A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that